ATC code A14

ATC code A14 Anabolic agents for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1][2][3] Subgroup A14 is part of the anatomical group A Alimentary tract and metabolism.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA14.^[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A14A Anabolic steroids

A14AA Androstan derivatives

A14AA01 Androstanolone

A14AA02 Stanozolol

A14AA03 Metandienone

A14AA04 Metenolone

A14AA05 Oxymetholone

A14AA06 Quinbolone

A14AA07 Prasterone

A14AA08 Oxandrolone

A14AA09 Norethandrolone

A14AB Estren derivatives

A14AB01 Nandrolone

A14AB02 Ethylestrenol

A14AB03 Oxabolone cipionate

A14B Other anabolic agents

References

1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. "ATC/DDD Index 2022: code A14". WHO Collaborating Centre for Drug Statistics Methodology.
5. "ATCvet Index 2022: code QA14". WHO Collaborating Centre for Drug Statistics Methodology.